A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback